[1]戴翠莲,姜黔峰,张赟.蛋白酶体抑制剂MG-132对心肌梗死后心衰大鼠心功能及心肌肌钙蛋白Ⅰ的影响[J].陆军军医大学学报(原第三军医大学学报),2011,33(01):45-49.
 Dai Cuilian,Jiang Qianfeng,Zhang Yun.Effects of proteasome inhibitor MG-132 on heart function and cardiac troponin I in rats with chronic heart failure caused by myocardial infarction[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(01):45-49.
点击复制

蛋白酶体抑制剂MG-132对心肌梗死后心衰大鼠心功能及心肌肌钙蛋白Ⅰ的影响(/HTML )
分享到:

陆军军医大学学报(原第三军医大学学报)[ISSN:1000-5404/CN:51-1095/R]

卷:
33卷
期数:
2011年第01期
页码:
45-49
栏目:
论著
出版日期:
2011-01-15

文章信息/Info

Title:
Effects of proteasome inhibitor MG-132 on heart function and cardiac troponin I in rats with chronic heart failure caused by myocardial infarction
作者:
戴翠莲姜黔峰张赟
遵义医学院附属医院心内科
Author(s):
Dai Cuilian Jiang Qianfeng Zhang Yun
Department of Cardiology, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou Province, 563000, China
关键词:
慢性心力衰竭泛素蛋白酶体系统肌钙蛋白I
Keywords:
chronic heart failure ubiqutin proteasome system cardiac troponin I
分类号:
R331.31; R363.273; R542.22
文献标志码:
A
摘要:
目的  探讨泛素蛋白酶体系统对心肌梗死后心衰大鼠心功能及心肌肌钙蛋白I的影响。  方法  将制作成功的心肌梗死后心衰大鼠模型纳入研究,45只大鼠随机分为:①MG-132组:结扎左冠状动脉前降支,腹腔内注射MG-132 0.1 mg/(kg·d)(溶于2 ml生理盐水);②心肌梗死(MI)组:结扎左冠状动脉前降支,腹腔内注射2 ml/d生理盐水;③假手术(Sham)组:手术过程同心肌梗死组,但只穿线通过左冠状动脉前降支不打结,腹腔内注射2 ml/d生理盐水。所有腹腔内注射持续7周后,检测各组大鼠心脏血流动力学及血清脑钠肽水平,电镜检测心肌肌小节结构变化,Real-time PCR及Western blot方法检测心肌cTnI的mRNA水平和蛋白质表达。  结果   与MI组相比,MG-132组大鼠心衰所致死亡率有降低趋势(0 vs 20%), LVPS及+dp/dtmax 升高(分别为[85.69±14.65) vs (71.22±7.89) mmHg, P<0.05;(2 327.57±597.96) vs (1 047.20±168.65) mmHg/s,P<0.01],LVEDP下降[(16.85±2.05) vs (23.40±6.08)mmHg,P<0.01],NT-proBNP水平降低[(1 474.15±702.61) vs (3 920.56±1 919.04) pg/ml,P<0.001];MG-132还改善了肌小节结构,上调cTnI的mRNA及蛋白质表达[分别为(2.4±1.1) vs (0.6±0.2),P<0.01;(0.83±0.07) vs (0.63±0.10),P<0.05]。  结论  MG-132改善了肌小节结构,与上调cTnI的mRNA及蛋白质表达有关。
Abstract:
Objective  To investigate the effects of proteasome inhibitor MG-132 on the ubiquitin-proteasome system and on heart function and cardiac troponin I (cTnI) in rats with chronic heart failure (CHF) caused by myocardial infarction (MI).   Methods  Coronary artery ligation was used to build animal models of CHF. Forty-five adult Sprague-Dawley rats were randomly divided into 3 groups: MG-132 group, MI group, and Sham group. In the MG-132 group, the ligation of left anterior descending coronary arteries and the intraperitoneal injection of MG-132 [0.1 mg/(kg·d), dissolved in 0.9% saline 2 ml] were performed. In the MI group, the ligation of left anterior descending coronary arteries and the intraperitoneal injection of saline (2 ml/d) were performed. In the Sham group, rats also underwent the intraperitoneal injection of saline (2 ml/d), but threads were only passed through the left anterior descending coronary arteries without completing the ligation. After intraperitoneal injection in the three groups continually for 7 weeks, hemodynamics and serum B-type natriuretic peptide level were measured, sarcomere morphology change was measured by electronic microscopy, and the mRNA level and protein expression of myocardial cTnI were investigated by real-time PCR and Western blotting.   Results  The MG-132 group, compared with the MI group, demonstrated lower mortality (0 vs 20%), higher systolic left ventricular pressure (LVPS) (85.69±14.65 mmHg vs 71.22±7.89 mmHg, P<0.05) and +dp/dtmax (2 327.57±597.96 mmHg/s vs 1 047.20±168.65 mmHg/s, P<0.001), and lower left ventricular end-diastolic pressure (LVEDP) (16.85±2.05 mmHg vs 23.40±6.08 mmHg, P<0.001) and NT-proBNP level (1 474.15±702.61 pg/ml vs 3 920.56±1 919.04 pg/ml, P<0.001). MG-132 improved the sarcomere morphology and upregulated the mRNA and protein expressions of myocardial cTnI (2.4±1.1 vs 0.6±0.2, P<0.01; 0.83±0.07 vs 0.63±0.10, P<0.05).   Conclusion  Our results demonstrate that inhibiting ubiquitin-proteasome system can improve the prognosis of CHF caused by myocardial infraction by decreasing the cTnI degradation. In addition, MG-132 can improve the sarcomere morphology, and this is associated with the upregulation of mRNA and protein expressions of myocardial cTnI.

相似文献/References:

[1]罗维,瞿广素.护理心理干预对慢性心力衰竭合并抑郁症患者心功能及生活质量的影响[J].陆军军医大学学报(原第三军医大学学报),2012,34(18):1918.
[2]彭艳,覃数,刘剑.血脂康对心力衰竭患者炎症因子和血管内皮功能的影响[J].陆军军医大学学报(原第三军医大学学报),2009,31(07):636.
[3]廖凯,杨成明,曾春雨,等.左心房容积指数对轻、中度慢性心力衰竭预后的价值[J].陆军军医大学学报(原第三军医大学学报),2010,32(02):173.
 Liao Kai,Yang Chengming,Zeng Chunyu,et al.Prognostic value of left atrial volume index in patients with mild to moderate chronic heart failure[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(01):173.
[4]张丽,崔丽君,谈丽丽,等.氨甲酰化促红细胞生成素对慢性心力衰竭大鼠心脏的保护作用[J].陆军军医大学学报(原第三军医大学学报),2011,33(01):50.
 Zhang Li,Cui Lijun,Tan Lili,et al.Experimental research on cardioprotective effects of carbamylated erythropoietin in rats with chronic heart failure[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(01):50.
[5]沈桂彬,张丽华.血清骨桥蛋白与慢性心力衰竭关系的分析[J].陆军军医大学学报(原第三军医大学学报),2011,33(05):468.
[6]王江,宋熔,田颖,等.心衰大鼠ACE/ACE2表达变化及血管紧张素转换酶抑制剂的干预作用[J].陆军军医大学学报(原第三军医大学学报),2008,30(19):1810.
 WANG Jiang,SONG Rong,TIAN Ying,et al.ACE and ACE2 alterations in congestive heart failure rats and intervention effect of benazepril[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(01):1810.
[7]黄丽,程婧,吴继雄,等.延续护理对心脏再同步化治疗患者心功能、生存质量和心理状态的影响[J].陆军军医大学学报(原第三军医大学学报),2014,36(03):292.
[8]余俊,朱武军,杜燕,等.慢性心力衰竭患者血清和肽素、心钠素、脑钠肽水平变化及其临床意义[J].陆军军医大学学报(原第三军医大学学报),2014,36(03):296.
[9]王真真,刘地川,蔡敏,等.别嘌呤醇对慢性心衰大鼠心功能的改善作用[J].陆军军医大学学报(原第三军医大学学报),2014,36(10):1021.
 Wang Zhenzhen,Liu Dichuan,Cai Min,et al.Allopurinol improves cardiac function of chronic heart failure rats[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(01):1021.

更新日期/Last Update: 2011-01-11